MedTrace Logo

NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden

NCT04740645 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1099551

Last updated 2025-12-03

No results posted yet for this study

Summary

A study using medical records to evaluate safety issues for the NOCDURNA drug using national register data from Denmark and Sweden, and a health care register covering parts of Germany.

Conditions

  • Adverse Drug Event

Interventions

OTHER

NOCDURNA Cohort

Non intervention

OTHER

LUTS Cohort

Non intervention

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Global Clinical Compliance · Ferring Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-13
Primary Completion
2023-11-01
Completion
2023-11-01
FDA Drug
Yes

Countries

  • Denmark
  • Germany
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04740645 on ClinicalTrials.gov